We next stained the 36 tumor specimens for IFNγ by immunohistochemistry and found that IFNγ expression localized predominantly to the CD3+ T-cell infiltrate, with some staining also co-localizing CK19 and E-Cadherin-expressing epithelial tissues (Figure 6H). The gene discussed is KRT19; the disease is neoplasm.